1199SEIU Funds

Blog

  • Seasonal Herbs and Botanicals for Better Health

    Seasonal Herbs and Botanicals for Better Health

    Seasonal Herbs and Botanicals for Better Health

    Learn about the connection between what you eat and how you think and feel, as well as about foods that can feed both your body and mind—without emptying your wallet.

    More
  • “The COVID-19 Vaccine Is Your Best Defense”

    “The COVID-19 Vaccine Is Your Best Defense”

  • Dr. Lantigua on COVID-19 Vaccinations

    Dr. Lantigua on COVID-19 Vaccinations

    Mensaje del Dr. Rafael Lantigua

    La llegada de las vacunas contra la COVID-19 promete el tan esperado alivio para un sistema de salud sobrecargado y para los trabajadores esenciales de la salud que prestan servicio en las primeras líneas de la pandemia. Con respecto a la vacuna contra la gripe, colocarse la vacuna contra la COVID-19 es la mejor manera de protegerse a sí mismo, a sus seres queridos y a los que cuida de los efectos peligrosos del virus, y con el tiempo podría ayudar a eliminar por completo el virus. Las vacunas se han revisado y evaluado minuciosamente para determinar su seguridad y eficacia, y solo se observaron efectos secundarios mínimos.

    Si bien colocarse la vacuna es su elección, le recomiendo que lo haga como una primera línea de defensa para usted y las personas a las que presta servicio. Visite nuestra sección de preguntas frecuentes para obtener más información sobre la COVID-19 y las vacunas.

    A Message from Dr. Rafael Lantigua

    The arrival of the COVID-19 vaccines promises much-needed relief for an over-burdened health system and the essential healthcare workers serving on the frontlines of the pandemic. As with the flu shot, getting vaccinated against COVID-19 is the best way to protect yourself, your loved ones and those you care for from the dangerous effects of the virus – and with time could help eliminate the virus altogether. The vaccines have been thoroughly reviewed and tested for safety and effectiveness, revealing only minimal side effects.

    Although getting vaccinated is a choice, I encourage you to do so as a first line of defense for yourself and those you serve. Visit our FAQs section for more information about COVID-19 and the vaccines.

  • Opening Remarks

    Opening Remarks

    Opening Remarks

    Includes statements from webinar hosts Sandi Vito (TEF) and co-sponsors Marc Kramer (LVHH) and Maria Castaneda (1199SEIU UHWE), along with a pre-recorded message from 1199SEIU UHWE President George Gresham and his daughter, Siana Gresham. (Running time: 11 minutes, 18 seconds| Slides 1-5)

    Downloadable Resources

    Presentations and other resources related to the webinar.

  • The Development of COVID-19 Vaccines: A “Pandemic Speed”

    The Development of COVID-19 Vaccines: A “Pandemic Speed”

    “The Development of COVID-19 Vaccines: A “Pandemic Speed” by Dr. Chris Pernell, University Hospital, Newark NJ

    Dr. Pernell discusses the spread of COVID-19 and the development of the vaccines through a health equity lens. She pays particular attention to the pandemic’s effect on communities of color and how that will affect vaccine distribution. (Running time: 26 minutes, 14 seconds | Slides 6-23)

    Presentation Outline

    Use the timestamps below.

    00:00 | Slide 6 | Bio of Chris T. Pernell, MD, MPH, FACPM, Chief Strategic Integration and Equity Officer, University Hospital, Newark, NJ 01:03 | Slide 6 | Start of presentation 01:36 | Slide 7 | Title slide

    Remembering those we have lost or who have been sick

    02:28 | Slide 8 | Faces of the pandemic 03:23 | Slide 9 | Remembering my father 04:18 | Slide 10 | My sister, a COVID-19 “long-hauler” 05:32 | Slide 11 | Overview of the coronavirus pandemic

    Health equity and the pandemic’s effect on communities of color

    07:48 | Slide 12 | Pandemic’s impact on Black and Brown communities 09:35 | Slide 13 | Racial groups more likely to die of COVID-19 (chart) 10:05 | Slide 14 | Hospitalization and death by race/racism as a pre-existing condition

    Development of the COVID-19 vaccine

    11:12 | Slide 15 | How did we get here 13:33 | Slide 16 | Key steps to emergency use authorization (EUA) 16:04 | Slide 17 | Top coronavirus vaccines (study) 16:54 | Slide 18 | Vaccine timeline 19:00 | Slide 19 | How is the coronavirus vaccine development different? (1) 21:24 | Slide 20 | How is the coronavirus vaccine development different? (2)

    Racial equity and vaccines

    23:21 | Slide 21 | Racial Equity and the Vaccine/Black Americans Trail in Covid Vaccinations (chart) 25:07 | Slide 22 | Demonstrating Trustworthiness and Building Trus

    Downloadable Resources

    Presentations and other resources related to the webinar.

  • COVID-19 Vaccine Update

    COVID-19 Vaccine Update

    “COVID-19 Vaccine Update” by Dr. Shobha Swaminathan, University Hospital, Newark NJ

    Dr. Swaminathan discusses the various strategies for developing vaccines, particularly the mRNA approach employed by Moderna and Pfizer/Biontech—the first two pharmaceutical companies to release vaccines. She also discusses vaccine efficacy, allergic reactions and contraindications for pregnant women. Note: Slides appearing in the video differ slightly from those available for download. (Running time: 23 minutes, 51 seconds | Slides 24-49)

    Presentation Outline

    Use the timestamps below.

    00:00 | Slide 24 | Bio of Shobha Swaminathan, MD, Director of HIV Programs, University Hospital, Newark, NJ, Associate Professor of Medicine, Rutgers New Jersey Medical School 01:04 | Slide 24 | Start of presentation

    Overview

    01:17 | Slide 26 | SARS CoV-2, infections and deaths 01:47 | Slide 27 | Why is this important in minority communities (chart)

    Vaccine strategies

    01:53 | Slide 28 | Vaccine strategies for SARS CoV-2 04:23 | Slide 29 | Current phase 3 studies (not shown in webinar video) 08:10 | Slide 30 | mRNA approaches 09:23 | Slide 31 | mRNA vaccines (graphic)

    The Moderna mRNA-1273 vaccine

    11:20 | Slide 32 | Moderna mRNA-1273 vaccine 11:56 | Slide 33 | Moderna mRNA-1273 vaccine phase 3 COVE study 12:30 | Slide 34 | COVE study demographics 12:56 | Slide 35 | Adverse events 13:45 | Slide 36 | Vaccine efficacy 14:19 | Slide 37 | Other key points  

    The Pfizer/BionTech NBT162b2 vaccine

    15:12 | Slide 38 | Pfizer/BionTech BNT162b2 vaccine 15:38 | Slide 39 | Phase 3 clinical study 15:55 | Slide 40 | Local and systemic reactions 16:47 | Slide 41 | Vaccine efficacy 17:37 | Slide 42 | Allergic reactions 18:13 | Slide 43 | Allergic reactions (2)  

    Recommendations and precautions

    18:59 | Slide 44 | Other key points 19:04 | Slide 45 | Pregnant women 20:44 | Slide 46 | CDC recommendations* 21:23 | Slide 47 | Ongoing monitoring 22:15 | Slide 48 | Continuing precautions 22:46 | How to sign-up for the vaccine in New Jersey* 23:41 | Slide 49 | Research team and contact information   *Not available in slides distributed for download

    Downloadable Resources

    Presentations and other resources related to the webinar.

  • NYS Vaccination Update

    NYS Vaccination Update

    “NYS Vaccination Update” by Zeynep Sumer-King, Greater New York Hospital Association

    Ms. Sumer-King discusses New York State’s plan to distribute COVID-19 vaccines. Topics covered include current vaccine phases, eligibility and how to obtain access. (Running time: 16 minutes, 43 seconds | Slides 50-60)

    Presentation Outline

    Use the timestamps below.

    00:00 | Slide 50 | Bio of Zeynep Sumer-King, Vice President, Regulatory and Professional Affairs, Greater New York Hospital Association 00:53 | Slide 50 | Start of presentation

    Overview

    01:19 | Slide 51 | Title slide: NYS Vaccination Plan 01:20 | Slide 52 | NYS COVID-19 Vaccine Plan: Overview

    Eligibility

    04:44 | Slide 53 | NYS eligibility: vaccine distribution phases 05:34 | Slide 54 | Currently eligible populations: Phase 1A – Healthcare workers, long-term and congregate care 07:16 | Slide 55 | Currently eligible populations: Phase 1B – Older adults and grocery workers 07:49 | Slide 56 | Currently eligible populations: Phase 1B – Police, fire, correctional workers 07:57 | Slide 57 | Currently eligible populations: Phase 1B – Child care workers and teachers, public transit workers, shelters, and supportive housing 08:22 | Slide 58 | Future eligibility – Other essential workers, people with underlying health conditions

    Current status of plan

    09:00 | Slide 59 | The evolving NYS COVID-19 Vaccine Plan – Where we are now 13:31 | Slide 60 | Where to get vaccinated in NYS

    Downloadable Resources

    Presentations and other resources related to the webinar.

  • Massachussetts Vaccine Update

    Massachussetts Vaccine Update

    “Massachussetts Vaccine Update” by Kevin Cranston, Massachusetts Department of Public Health

    Mr. Cranston discusses the rollout of COVID-19 vaccines in Massachusetts. Topics covered include self-care for healthcare workers, vaccine eligibility and the various vaccine-location types. (Running time: 17 minutes, 44 seconds | Slides 61-63)

    Presentation Outline

    Use the timestamps below.

    00:00 Bio of Kevin Cranston, MDiv, Assistant Commissioner & Director, Bureau of Infectious Diseases & Laboratory Sciences, Massachusetts Department of Public Health (MADPH) 00:51 Start of presentation

    Overview

    01:01 MADPH role during the pandemic and the importance of vaccines. 02:41 Recognizing the importance of healthcare provders 04:07 The importance self-care and receiving the vaccine.

    Eligibility and Phased Rollout

    05:12 Eligibility health equity and phased distribution. 05:37 Phase 1 – Eligibility for healthcare workers working in MA. 07:16 Phase 2 – People with health conditions. 07:44 Website to determine eligibility.

    Vaccine Locations

    08:10 Overview 08:19 Mass vaccination sites at stadiums and parks. 09:15 Employer-based vaccine distribution & pharmacy partnerships 10:21 Hospital “Outfacing Clinics” for workers at smaller facilities. 11:38 Local Boards of Health for first-responders, police and firefighters. 12:03 Distribution at Pharmacies. 12:43 Location and eligibility web resource.

    Conclusion

    13:00 Challenges of limited supply. 14:22 New ways of providing vaccination. 14:50 Overcoming reluctance to receive the vaccine. 16:35 Current status of the Massachusetts plan. 16:50 What to bring to your vaccine appointment

    Downloadable Resources

    Presentations and other resources related to the webinar.

  • COVID-19 Vaccines in the Pipeline

    COVID-19 Vaccines in the Pipeline

    “COVID-19 Vaccines in the Pipeline” by Dr. Magdalena Sobieszczyk

    Dr. Sobiezczyk discusses vaccines currently in development, particularly “virus vector vaccines” being developed by companies such as AstraZeneca, which offer an alternative approach to the mRNA vaccines developed by Pfizer and Moderna. (Running time: 7 minutes, 03 seconds | Slides 65-71)

    Presentation Outline

    Use the timestamps below.

    00:00 | Slide 65 | Bio of Magdalena Sobieszczyk MD, MPH, Associate Professor of Medicine Columbia, University Vagelos College of Physicians and Surgeons, Chief of Infectious Diseases, NY-Presbyterian/Columbia University Irving Medical Center, NYC 00:48 | Slide 66 | Start of presentation 01:10 | Slide 67 | Virus vector vaccines — AstraZeneca & J&J/Janssen vaccine 03:05 | Slide 68 | Global clinical development of AstraZeneca AZD122 vaccine 04:04 | Slide 69 | What we know about the AstraZeneca vaccine from studies outside the US. 05:33 | Slide 70 | Vaccine studies in New York City. 06:20 | Slide 71 | Thank you and the New York vaccine team and volunteers.

    Downloadable Resources

    Presentations and other resources related to the webinar.

  • Panel Discussion and Q&A

    Panel Discussion and Q&A

    Panel Discussion and Q&A

    Panelists answer questions from healthcare workers about COVID-19 vaccines. Topics covered include what to bring to vaccine locations, side effects and allergic reactions, the importance of continuing to wear a mask, taking the vaccine with other underlying health conditions, and more. (Running time: 34 minutes 30 seconds | Slides 72-73)

    Downloadable Resources

    Presentations and other resources related to the webinar.